20 (AIDX) Equity Ratio (2024 - 2026)

20 posted quarterly Equity Ratio of 0.44 for Q1 2026, up 9566.94% on a QoQ basis from 0.0 in Q4 2025.

20 (AIDX) has 3 years of Equity Ratio data on file, last reported at 0.44 in Q1 2026.

  • For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 0.44; the trailing twelve-month figure through Mar 2026 stood at 0.44 (changed N/A YoY), and the FY2025 full-year result was 0.0, down 101.11% from the prior year.
  • Equity Ratio for Q1 2026 stood at 0.44, up from 0.0 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.44 in Q1 2026 and bottomed at 0.0 in Q4 2025.
  • The 3-year median for Equity Ratio is 0.42 (2024), against an average of 0.29.
  • Peak annual rise in Equity Ratio reached 101.11% in 2025, while the deepest fall reached 101.11% in 2025.
  • A 3-year view of Equity Ratio shows it stood at 0.42 in 2024, then tumbled by 101.11% to 0.0 in 2025, then jumped by 9566.94% to 0.44 in 2026.
  • The last three Equity Ratio figures came in at 0.44 (Q1 2026), 0.0 (Q4 2025), and 0.42 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 20 - - 62,884.00 0.44

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.44
Dec 31, 2025 0.00
Dec 31, 2024 0.42